| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |